2932 related articles for article (PubMed ID: 18654426)
21. [Nanoscale drug carriers for traditional Chinese medicine research and development].
Yi CX; Yu JN; Xu XM
Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(16):1936-40. PubMed ID: 19086622
[TBL] [Abstract][Full Text] [Related]
22. Magnetic nanoparticles: prospects in cancer imaging and therapy.
Tang M; Russell PJ; Khatri A
Discov Med; 2007 Jun; 7(38):68-74. PubMed ID: 18093468
[TBL] [Abstract][Full Text] [Related]
23. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
Raj R; Mongia P; Kumar Sahu S; Ram A
Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
Greco F; Vicent MJ
Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
[TBL] [Abstract][Full Text] [Related]
25. Not only anticancer drugs but also enzymes can be encapsulated in either micelle or other carrier for the treatment of cancer.
Tan Q; Zhang J; Zhang L
Med Hypotheses; 2010 Feb; 74(2):396-7. PubMed ID: 19762160
[No Abstract] [Full Text] [Related]
26. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.
Chehelgerdi M; Chehelgerdi M; Allela OQB; Pecho RDC; Jayasankar N; Rao DP; Thamaraikani T; Vasanthan M; Viktor P; Lakshmaiya N; Saadh MJ; Amajd A; Abo-Zaid MA; Castillo-Acobo RY; Ismail AH; Amin AH; Akhavan-Sigari R
Mol Cancer; 2023 Oct; 22(1):169. PubMed ID: 37814270
[TBL] [Abstract][Full Text] [Related]
27. Ligand-Installed Nanocarriers toward Precision Therapy.
Mi P; Cabral H; Kataoka K
Adv Mater; 2020 Apr; 32(13):e1902604. PubMed ID: 31353770
[TBL] [Abstract][Full Text] [Related]
28. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
[TBL] [Abstract][Full Text] [Related]
29. Review: nanoparticles in drug delivery for the treatment of cancer.
Arayne MS; Sultana N
Pak J Pharm Sci; 2006 Jul; 19(3):258-68. PubMed ID: 16935836
[TBL] [Abstract][Full Text] [Related]
30. Emerging advances in nanomedicine with engineered gold nanostructures.
Webb JA; Bardhan R
Nanoscale; 2014 Mar; 6(5):2502-30. PubMed ID: 24445488
[TBL] [Abstract][Full Text] [Related]
31. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
Danhier F; Feron O; Préat V
J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
[TBL] [Abstract][Full Text] [Related]
32. Nanostructured hyaluronic acid-based materials for active delivery to cancer.
Ossipov DA
Expert Opin Drug Deliv; 2010 Jun; 7(6):681-703. PubMed ID: 20367530
[TBL] [Abstract][Full Text] [Related]
33. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy.
Prakash S; Malhotra M; Shao W; Tomaro-Duchesneau C; Abbasi S
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1340-51. PubMed ID: 21756952
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.
Gindy ME; Prud'homme RK
Expert Opin Drug Deliv; 2009 Aug; 6(8):865-78. PubMed ID: 19637974
[TBL] [Abstract][Full Text] [Related]
35. Ligand-based targeted therapy for cancer tissue.
Das M; Mohanty C; Sahoo SK
Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
[TBL] [Abstract][Full Text] [Related]
36. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
Cabral H; Nishiyama N; Kataoka K
Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933
[TBL] [Abstract][Full Text] [Related]
37. Organic nanocarriers for cancer drug delivery.
López-Dávila V; Seifalian AM; Loizidou M
Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
[TBL] [Abstract][Full Text] [Related]
38. A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers.
Saul JM; Annapragada AV; Bellamkonda RV
J Control Release; 2006 Sep; 114(3):277-87. PubMed ID: 16904220
[TBL] [Abstract][Full Text] [Related]
39. Biomedical nanotechnology for cancer.
Pope-Harman A; Cheng MM; Robertson F; Sakamoto J; Ferrari M
Med Clin North Am; 2007 Sep; 91(5):899-927. PubMed ID: 17826110
[TBL] [Abstract][Full Text] [Related]
40. Nanostructure-mediated drug delivery.
Hughes GA
Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
